MedPath

Contrast Sensitivity in Glaucoma

Conditions
Primary Open Angle Glaucoma
Secondary Open Angle Glaucoma Due to PEX
Registration Number
NCT00947869
Lead Sponsor
University of Erlangen-Nürnberg
Brief Summary

The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity. No therapeutic studies are performed.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age > 18
  • Best corrected visual acuity 0.8 or better
  • European
Exclusion Criteria
  • eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich are not due to PEX, diseases involving retina, condition after ophthalmological operations or trauma, cataract, diseases concerning the refractive system, age-related macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia
  • Any neurological diseases
  • Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
  • Systemic drugs with potentially ocular involvement
  • ocular drugs

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Eye Hospital

🇩🇪

Erlangen, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath